Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Apr 4;21(7):2509.
doi: 10.3390/ijms21072509.

Potential Molecular Pathways Related to Pulmonary Artery Aneurysm Development: Lessons to Learn from the Aorta

Affiliations
Review

Potential Molecular Pathways Related to Pulmonary Artery Aneurysm Development: Lessons to Learn from the Aorta

Jorge Nuche et al. Int J Mol Sci. .

Abstract

Pulmonary arterial hypertension (PAH) is a rare disease caused by pulmonary vascular remodeling. Current vasodilator treatments have substantially improved patients' survival. This improved survival has led to the appearance of complications related to conditions previously underdiagnosed or even ignored, such as pulmonary artery aneurysm (PAA). The presence of a dilated pulmonary artery has been shown to be related to an increased risk of sudden cardiac death among PAH patients. This increased risk could be associated to the development of left main coronary artery compression or pulmonary artery dissection. Nevertheless, very little is currently known about the molecular mechanisms related to PAA. Thoracic aortic aneurysm (TAA) is a well-known condition with an increased risk of sudden death caused by acute aortic dissection. TAA may be secondary to chronic exposure to classic cardiovascular risk factors. In addition, a number of genetic variants have been shown to be related to a marked risk of TAA and dissection as part of multisystemic syndromes or isolated familial TAA. The molecular pathways implied in the development of TAA have been widely studied and described. Many of these molecular pathways are involved in the pathogenesis of PAH and could be involved in PAA. This review aims to describe all these common pathways to open new research lines that could help lead to a better understanding of the pathophysiology of PAH and PAA and their clinical implications.

Keywords: aortic aneurysm; gene; molecular biology; pulmonary arterial hypertension; pulmonary artery aneurysm.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Graphical abstract representing genes related to thoracic aortic aneurysms that also encode for proteins implicated in the pathogenesis of pulmonary arterial hypertension (extracellular matrix stiffness (left column), increased cell proliferation (right column)). Syndromes in which pulmonary and aortic aneurysms may be present are also listed.

References

    1. Nuche J., Montero Cabezas J.M., Jiménez López-Guarch C., Velázquez Martín M., Alonso Charterina S., Revilla Ostolaza Y., Arribas Ynsaurriaga F., Escribano Subías P. Frequency, Predictors, and Prognostic Impact of Pulmonary Artery Aneurysms in Patients With Pulmonary Arterial Hypertension. Am. J. Cardiol. 2019;123:474–481. doi: 10.1016/j.amjcard.2018.10.028. - DOI - PubMed
    1. Boerrigter B., Mauritz G.J., Marcus J.T., Helderman F., Postmus P.E., Westerhof N., Vonk-Noordegraaf A. Progressive dilatation of the main pulmonary artery is a characteristic of pulmonary arterial hypertension and is not related to changes in pressure. Chest. 2010;138:1395–1401. doi: 10.1378/chest.10-0363. - DOI - PubMed
    1. Duijnhouwer A.L., Navarese E.P., Van Dijk A.P., Loeys B., Roos-Hesselink J.W., De Boer M.J. Aneurysm of the Pulmonary Artery, a Systematic Review and Critical Analysis of Current Literature. Congenit. Heart Dis. 2016;11:102–109. doi: 10.1111/chd.12316. - DOI - PubMed
    1. Kreibich M., Siepe M., Kroll J., Höhn R., Grohmann J., Beyersdorf F. Aneurysms of the pulmonary artery. Circulation. 2015;131:310–316. doi: 10.1161/CIRCULATIONAHA.114.012907. - DOI - PubMed
    1. Sakata K., Satoh T., Isaka A., Uesugi Y., Furuya M., Matsushita K., Yoshino H. Cardiac dysfunction of pulmonary artery aneurysm in patients with pulmonary arterial hypertension. Int. J. Cardiol. 2017;228:1035–1040. doi: 10.1016/j.ijcard.2016.10.082. - DOI - PubMed

MeSH terms